Shanghai - Delayed Quote CNY
Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS)
14.79
+0.28
+(1.93%)
At close: May 23 at 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,090,830.67
1,094,382.34
927,075.09
1,493,267.94
1,823,733.13
Cost of Revenue
179,935.17
181,511.41
130,446.55
176,181.87
157,298.58
Gross Profit
910,895.51
912,870.92
796,628.55
1,317,086.07
1,666,434.55
Operating Expense
817,112.57
826,925.81
748,482.09
1,162,124.61
1,204,819.47
Operating Income
93,782.94
85,945.12
48,146.45
154,961.46
461,615.07
Net Non Operating Interest Income Expense
24,771.29
22,901.48
38,476.94
47,032.10
6,060.26
Pretax Income
268,761.44
349,698.88
132,154.50
238,391.47
477,699.67
Tax Provision
24,429.10
33,801.65
-7,180.16
-10,599.14
31,841.06
Net Income Common Stockholders
253,327.90
325,390.30
139,785.74
248,990.62
445,858.61
Basic EPS
0.60
0.77
0.33
0.59
1.20
Diluted EPS
0.60
0.77
0.33
0.59
1.20
Basic Average Shares
423,825.67
422,584.80
423,593.16
422,018
371,548.84
Diluted Average Shares
423,825.67
422,584.80
423,593.16
422,018
371,548.84
Total Operating Income as Reported
272,539.34
348,432.46
124,368.46
235,448.35
478,755.44
Total Expenses
997,047.74
1,008,437.22
878,928.64
1,338,306.48
1,362,118.06
Net Income from Continuing & Discontinued Operation
253,327.90
325,390.30
139,785.74
248,990.62
445,858.61
Normalized Income
123,690.33
120,736.45
139,608.19
255,969.78
446,474.74
Interest Income
34,677.54
36,416.23
45,542.84
48,283.67
7,319.82
Interest Expense
10,322.11
12,403.27
6,701.53
1,179.68
1,064.89
Net Interest Income
24,771.29
22,901.48
38,476.94
47,032.10
6,060.26
EBIT
279,083.54
362,102.15
138,856.03
239,571.16
478,764.56
EBITDA
279,083.54
441,939.78
202,732.83
292,685.05
519,891.09
Reconciled Cost of Revenue
179,935.17
181,511.41
130,446.55
176,181.87
157,298.58
Reconciled Depreciation
--
79,837.63
63,876.81
53,113.90
41,126.53
Net Income from Continuing Operation Net Minority Interest
253,327.90
325,390.30
139,785.74
248,990.62
445,858.61
Total Unusual Items Excluding Goodwill
142,599.14
226,552.22
236.73
-9,305.55
-660.14
Total Unusual Items
142,599.14
226,552.22
236.73
-9,305.55
-660.14
Normalized EBITDA
136,484.41
215,387.55
202,496.10
301,990.61
520,551.22
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
12,961.56
21,898.38
59.18
-2,326.39
-44
12/31/2021 - 10/26/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade